I agree, todays fantastic announcement is only the beginning of some continual quality news flow. There should be at least another US Hospital announcement before the end of this quarter.
Having Massachusetts on board not only validates the acceptance of ResApps technology as an important tool to diagnosis, but also creates a major attraction and talking point for the hospital. I'm sure ResApps technology will be integrated into their triage facilities post FDA approval and will set the stage for other world class hospitals to follow.
A world class hospital such as Massachusetts General would not be about to compromise their reputation over a hyped up app and a few dollars, they are much more than a business. The signatures required would have to been from some substantial physicians and medical professionals at the top.
Can't wait for the next few months of activity.
- Forums
- ASX - By Stock
- RAP
- Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX
Ann: Massachusetts General Hospital for US Clinical Study Site-RAP.AX, page-52
Currently unlisted. Proposed listing date: 4 SEPTEMBER 2024 #
-
- There are more pages in this discussion • 96 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)